Literature DB >> 24559826

Investigation on Chinese herbal medicine for primary dysmenorrhea: implication from a nationwide prescription database in Taiwan.

Hsing-Yu Chen1, Yi-Hsuan Lin1, Irene H Su2, Yu-Chun Chen3, Sien-Hung Yang4, Jiun-Liang Chen5.   

Abstract

OBJECTIVE: Primary dysmenorrhea is a common gynecological condition, for which Chinese herbal medicine (CHM) has been widely used in addition to western medicine. The aim of this study is to explore CHM commonly used to treat dysmenorrhea in young Chinese women.
DESIGN: Observational retrospective study.
SETTING: The National Health Insurance Research Database in Taiwan. POPULATION: Women aged from 13 to 25 years with single diagnosis of primary dysmenorrhea.
METHODS: CHM prescriptions made for primary dysmenorrhea women during 1998-2008 were extracted to build up CHM prescription database. Association rule mining was used to explore the prevalent CHM combination patterns in treating primary dysmenorrhea. MAIN OUTCOME MEASURES: Prevalence and mechanisms of CHM combinations.
RESULTS: Totally 57,315 prescriptions were analyzed and, on average, 5.3 CHM was used in one prescription. Dang-Gui-Shao-Yao-San (DGSYS) was the most commonly used herbal formula (27.2%), followed by Jia-Wei-Xiao-Yao-San (JWXYS) (20.7%) and Wen-Jing-Tang (WJT) (20.5%). Corydalis yanhusuo and Cyperus rotundus were the most commonly used single herb, found in 33.1% and 29.2% of all prescriptions. Additionally, C. yanhusuo with C. rotundus is the most commonly used two CHM in combination, accounting for 14.24% of all prescriptions, followed by DGSYS with C. yanhusuo (10.47%). Multi-target effects on primary dysmenorrhea, such as analgesia, mood modifying and hormone adjustment, were found among commonly prescribed CHM in this study.
CONCLUSIONS: This study discovered the potential importance of C. yanhusuo, C. rotundus and DGSYS in treating primary dysmenorrhea. Further clinical trials or bench studies are warranted based on the results. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Association rule mining; Chinese herbal medicine; Primary dysmenorrhea; The National Health Insurance Research Database

Mesh:

Substances:

Year:  2013        PMID: 24559826     DOI: 10.1016/j.ctim.2013.11.012

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  27 in total

1.  Involvement of a neutrophil-mast cell axis in the effects of Piper malacophyllum (C. PESL) C. DC extract and its isolated compounds in a mouse model of dysmenorrhoea.

Authors:  Nara Lins Meira Quintão; Jaqueline Pavesi Reis; Larissa Benvenutti; Roberta Nunes; Fernanda Capitanio Goldoni; Manuela Somensi Cozer; Priscila de Souza; Rita de Cássia Melo Vilhena de Andrade Fonseca da Silva; Jessica Melato; Carlos Rafael Vaz; Juliana Cristina Pereira Whitaker; Flavia Werner Jesuíno; Mariana Couto Costa; Maria Verônica Dávila Pastor; Angela Malheiros; Christiane Meyre-Silva; José Roberto Santin
Journal:  Inflammopharmacology       Date:  2022-07-22       Impact factor: 5.093

2.  Prescription patterns of herbal medicine for menopausal disorders in major Korean medicine hospitals: a multicenter retrospective study.

Authors:  Hye Won Lee; Tae-Young Choi; Myeong Soo Lee; Ju Ah Lee; Ji Hee Jun; Jiae Choi; Lin Ang; Chang-Hoon Lee; Jin-Moo Lee; Kyoung Sun Park; Dong Chul Kim; Se-Ran Jang; Jeong-Eun Yoo; Dong-Il Kim; Seong-Hee Cho; Seung-Jeong Yang; In Seon Lee; In-Suk Ahn; Dong-Nyung Lee; Chang-Min Choi; Mi-Hwa Song; Eunseop Kim
Journal:  Integr Med Res       Date:  2020-12-04

3.  Identifying chinese herbal medicine network for eczema: implications from a nationwide prescription database.

Authors:  Hsing-Yu Chen; Yi-Hsuan Lin; Sindy Hu; Sien-Hung Yang; Jiun-Liang Chen; Yu-Chun Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-22       Impact factor: 2.629

4.  Characteristics of traditional Chinese medicine users and prescription analysis for pediatric atopic dermatitis: a population-based study.

Authors:  Yu-Chun Chen; Yi-Hsuan Lin; Sindy Hu; Hsing-Yu Chen
Journal:  BMC Complement Altern Med       Date:  2016-06-08       Impact factor: 3.659

5.  Herbal medicine Shaofu Zhuyu decoction for primary dysmenorrhea: a systematic review protocol.

Authors:  Hoyoung Lee; Tae-Young Choi; Chang-Seon Myung; Myeong Soo Lee
Journal:  Syst Rev       Date:  2016-01-20

6.  Research of Herb-Partitioned Moxibustion for Primary Dysmenorrhea Patients Based on the LC-MS Metabonomics.

Authors:  Yu-Xia Ma; Xing-Yue Yang; Gang Guo; Dong-Qing Du; Yan-Pu Yu; Shu-Zhong Gao
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-01       Impact factor: 2.629

7.  Hedyotis diffusa Combined with Scutellaria barbata Are the Core Treatment of Chinese Herbal Medicine Used for Breast Cancer Patients: A Population-Based Study.

Authors:  Yuan-Chieh Yeh; Hsing-Yu Chen; Sien-Hung Yang; Yi-Hsien Lin; Jen-Hwey Chiu; Yi-Hsuan Lin; Jiun-Liang Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-09       Impact factor: 2.629

8.  Identifying Chinese herbal medicine for premenstrual syndrome: implications from a nationwide database.

Authors:  Hsing-Yu Chen; Ben-Shian Huang; Yi-Hsuan Lin; Irene H Su; Sien-Hung Yang; Jiun-Liang Chen; Jen-Wu Huang; Yu-Chun Chen
Journal:  BMC Complement Altern Med       Date:  2014-06-27       Impact factor: 3.659

9.  Integrated identification, qualification and quantification strategy for pharmacokinetic profile study of Guizhi Fuling capsule in healthy volunteers.

Authors:  Yun-Xi Zhong; Xiao-Liang Jin; Shi-Yin Gu; Ying Peng; Ke-Rong Zhang; Bing-Chen Ou-Yang; Yu Wang; Wei Xiao; Zhen-Zhong Wang; Ji-Ye Aa; Guang-Ji Wang; Jian-Guo Sun
Journal:  Sci Rep       Date:  2016-08-16       Impact factor: 4.379

10.  Herbal medicine (Gyejibongneyong-hwan) for treating primary dysmenorrhoea: a protocol for a systematic review of randomised controlled trials.

Authors:  Ju Ah Lee; Sunju Park; Jeeyoun Jung; Ji Hee Jun; Jiae Choi; Myeong Soo Lee
Journal:  BMJ Open       Date:  2016-09-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.